Abstract
Aspergillosis is an infrequent but commonly fatal infection among HIV- infected individuals. We review 342 cases of pulmonary Aspergillus infection that have been reported among HIV-infected patients, with a focus on invasive diseases, Invasive pulmonary aspergillosis usually occurs among patients with <50 CD4 cells/mm3. Major predisposing conditions include neutropenia and steroid treatment. Fever, cough, and dyspnea are each present in >60% of the cases. BAL is often suggestive, but biopsy specimens are necessary for definite diagnosis. Amphotericin B is the mainstay of treatment and morality is >80%. Avoiding neutropenia and judicious use of steroids may be helpful in prevention. Aggressive diagnostic approach, early initiation of treatment, adequate dosing of antifungals, and close follow-up may improve the currently dismal prognosis.
Original language | English (US) |
---|---|
Pages (from-to) | 251-262 |
Number of pages | 12 |
Journal | CHEST |
Volume | 114 |
Issue number | 1 |
DOIs | |
State | Published - 1998 |
Keywords
- AIDS
- Amphotericin B
- Aspergillosis
- Fungal infection
- HIV
- Itraconazole
- Liposomal amphotericin B
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine
- Critical Care and Intensive Care Medicine
- Cardiology and Cardiovascular Medicine